SENTINELONE INC -CLASS A (1SUS.MI) Fundamental Analysis & Valuation

BIT:1SUS • US81730H1095

Current stock price

10.95 EUR
-0.3 (-2.67%)
Last:

This 1SUS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. 1SUS.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1SUS was profitable.
  • In the past year 1SUS had a positive cash flow from operations.
  • In the past 5 years 1SUS always reported negative net income.
  • In the past 5 years 1SUS reported 4 times negative operating cash flow.
1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCF1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • 1SUS's Return On Assets of -16.91% is on the low side compared to the rest of the industry. 1SUS is outperformed by 80.17% of its industry peers.
  • Looking at the Return On Equity, with a value of -26.54%, 1SUS is doing worse than 76.72% of the companies in the same industry.
Industry RankSector Rank
ROA -16.91%
ROE -26.54%
ROIC N/A
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
1SUS.MI Yearly ROA, ROE, ROIC1SUS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

  • 1SUS has a Gross Margin (74.69%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of 1SUS has grown nicely.
  • 1SUS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
1SUS.MI Yearly Profit, Operating, Gross Margins1SUS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 1SUS.MI Health Analysis

2.1 Basic Checks

  • 1SUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 1SUS has more shares outstanding
  • Compared to 5 years ago, 1SUS has more shares outstanding
  • 1SUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1SUS.MI Yearly Shares Outstanding1SUS.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
1SUS.MI Yearly Total Debt VS Total Assets1SUS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • 1SUS has an Altman-Z score of 1.94. This is not the best score and indicates that 1SUS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 1SUS has a Altman-Z score (1.94) which is comparable to the rest of the industry.
  • There is no outstanding debt for 1SUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.94
ROIC/WACCN/A
WACC11.14%
1SUS.MI Yearly LT Debt VS Equity VS FCF1SUS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • 1SUS has a Current Ratio of 1.52. This is a normal value and indicates that 1SUS is financially healthy and should not expect problems in meeting its short term obligations.
  • 1SUS's Current ratio of 1.52 is in line compared to the rest of the industry. 1SUS outperforms 53.45% of its industry peers.
  • A Quick Ratio of 1.52 indicates that 1SUS should not have too much problems paying its short term obligations.
  • The Quick ratio of 1SUS (1.52) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
1SUS.MI Yearly Current Assets VS Current Liabilites1SUS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. 1SUS.MI Growth Analysis

3.1 Past

  • 1SUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1800.00%, which is quite impressive.
  • The Revenue has grown by 24.09% in the past year. This is a very strong growth!
  • Measured over the past years, 1SUS shows a very strong growth in Revenue. The Revenue has been growing by 77.59% on average per year.
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.7%
Revenue 1Y (TTM)24.09%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%22.91%

3.2 Future

  • 1SUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 75.02% yearly.
  • Based on estimates for the next years, 1SUS will show a very strong growth in Revenue. The Revenue will grow by 20.85% on average per year.
EPS Next Y289.13%
EPS Next 2Y148.24%
EPS Next 3Y106.38%
EPS Next 5Y75.02%
Revenue Next Year22.54%
Revenue Next 2Y21.29%
Revenue Next 3Y19.9%
Revenue Next 5Y20.85%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1SUS.MI Yearly Revenue VS Estimates1SUS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 1B 2B 3B
1SUS.MI Yearly EPS VS Estimates1SUS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

3

4. 1SUS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1SUS is valuated quite expensively with a Price/Earnings ratio of 73.00.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1SUS is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of 1SUS to the average of the S&P500 Index (26.91), we can say 1SUS is valued expensively.
  • A Price/Forward Earnings ratio of 41.29 indicates a quite expensive valuation of 1SUS.
  • 1SUS's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, 1SUS is valued quite expensively.
Industry RankSector Rank
PE 73
Fwd PE 41.29
1SUS.MI Price Earnings VS Forward Price Earnings1SUS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1SUS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 95.79
EV/EBITDA N/A
1SUS.MI Per share data1SUS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • 1SUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1SUS's earnings are expected to grow with 106.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y148.24%
EPS Next 3Y106.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1SUS.MI Dividend Analysis

5.1 Amount

  • No dividends for 1SUS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1SUS.MI Fundamentals: All Metrics, Ratios and Statistics

SENTINELONE INC -CLASS A

BIT:1SUS (2/24/2026, 7:00:00 PM)

10.95

-0.3 (-2.67%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-04
Earnings (Next)03-12
Inst Owners79.23%
Inst Owner ChangeN/A
Ins Owners0.86%
Ins Owner ChangeN/A
Market Cap3.72B
Revenue(TTM)955.65M
Net Income(TTM)-411.29M
Analysts77.73
Price Target18.22 (66.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.2%
Min EPS beat(2)29.34%
Max EPS beat(2)37.07%
EPS beat(4)4
Avg EPS beat(4)66.06%
Min EPS beat(4)23.01%
Max EPS beat(4)174.81%
EPS beat(8)7
Avg EPS beat(8)80.73%
EPS beat(12)11
Avg EPS beat(12)65.4%
EPS beat(16)15
Avg EPS beat(16)53.64%
Revenue beat(2)0
Avg Revenue beat(2)-1.73%
Min Revenue beat(2)-1.95%
Max Revenue beat(2)-1.5%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-1.95%
Max Revenue beat(4)-0.52%
Revenue beat(8)2
Avg Revenue beat(8)-0.85%
Revenue beat(12)4
Avg Revenue beat(12)-0.41%
Revenue beat(16)8
Avg Revenue beat(16)0.68%
PT rev (1m)-11.62%
PT rev (3m)N/A
EPS NQ rev (1m)-18.79%
EPS NQ rev (3m)-18.71%
EPS NY rev (1m)2.48%
EPS NY rev (3m)2.57%
Revenue NQ rev (1m)-0.7%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 73
Fwd PE 41.29
P/S 4.52
P/FCF 95.79
P/OCF 62.8
P/B 2.79
P/tB 8.69
EV/EBITDA N/A
EPS(TTM)0.15
EY1.37%
EPS(NY)0.27
Fwd EY2.42%
FCF(TTM)0.11
FCFY1.04%
OCF(TTM)0.17
OCFY1.59%
SpS2.42
BVpS3.93
TBVpS1.26
PEG (NY)0.25
PEG (5Y)N/A
Graham Number3.64
Profitability
Industry RankSector Rank
ROA -16.91%
ROE -26.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.69%
FCFM 4.72%
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 48.39%
Cap/Sales 2.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z 1.94
F-Score6
WACC11.14%
ROIC/WACCN/A
Cap/Depr(3y)58.32%
Cap/Depr(5y)105.17%
Cap/Sales(3y)3.59%
Cap/Sales(5y)4.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.7%
EPS Next Y289.13%
EPS Next 2Y148.24%
EPS Next 3Y106.38%
EPS Next 5Y75.02%
Revenue 1Y (TTM)24.09%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%22.91%
Revenue Next Year22.54%
Revenue Next 2Y21.29%
Revenue Next 3Y19.9%
Revenue Next 5Y20.85%
EBIT growth 1Y5.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year336.9%
EBIT Next 3Y92.12%
EBIT Next 5YN/A
FCF growth 1Y144.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.7%
OCF growth 3YN/A
OCF growth 5YN/A

SENTINELONE INC -CLASS A / 1SUS.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SENTINELONE INC -CLASS A?

ChartMill assigns a fundamental rating of 4 / 10 to 1SUS.MI.


Can you provide the valuation status for SENTINELONE INC -CLASS A?

ChartMill assigns a valuation rating of 3 / 10 to SENTINELONE INC -CLASS A (1SUS.MI). This can be considered as Overvalued.


Can you provide the profitability details for SENTINELONE INC -CLASS A?

SENTINELONE INC -CLASS A (1SUS.MI) has a profitability rating of 1 / 10.


Can you provide the financial health for 1SUS stock?

The financial health rating of SENTINELONE INC -CLASS A (1SUS.MI) is 6 / 10.